Responses
Clinical/translational cancer immunotherapy
Original research
Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.